Clonidine HCL

DRUG3 trials

Sponsors

National Institute on Drug Abuse (NIDA), Johns Hopkins University, Wake Forest University Health Sciences

Conditions

Neonatal Abstinence SyndromeNephrectomy / MethodsPain ManagementRenal Carcinoma

Phase 2

Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome

CompletedNCT00510016

National Institute on Drug Abuse (NIDA)Neonatal Abstinence Syndrome

Start: 2002-07-31End: 2005-12-31Updated: 2017-01-11

Clonidine to Treat Iatrogenic-induced Opioid Dependence in Infants

TerminatedNCT01360450

Johns Hopkins UniversityNeonatal Abstinence Syndrome

Start: 2011-07-31End: 2014-12-31Updated: 2017-09-13

Phase 3

R.E.C.K vs Exparel in Robotic Nephrectomy

RecruitingNCT07092566

Wake Forest University Health SciencesNephrectomy / Methods, Pain Management, Renal Carcinoma

Start: 2025-11-14End: 2027-10-01Target: 170Updated: 2026-01-20